Browse CATs

Browse CATs  internal medicine  endocrine and metabolic disorders  diabetic ketoacidosis

Diagnosis Harm/ aetiology Prognosis Therapy

Diabetes mellitus a diabetic team intervention reduced readmissions Level of evidence 1b Expiry Date October Diabetic ketoacidosis the speed of fluid replacement did not clearly affect biochemical improvement. Level of evidence 1b- Expiry Date October 2003 Diabetic ketoacidosis hypertonic dextrose did not speed biochemical resolution. Level of evidence 1b- Expiry Date October 2003 Diabetic ketoacidosis less hypoglycaemia or hypokalaemia on low-dose insulin regimens. Level of evidence 1b Expiry Date October 2003 Diabetic ketoacidosis no clear benefit from continuous infusion. Level of evidence 1b- Expiry Date October 2003 Diabetic ketoacidosis no clear benefit from phosphate supplementation. Level of evidence 1b- Expiry Date October 2003 Diabetic ketoacidosis no clear benefit from phosphate supplementation. Level of evidence 1b- Expiry Date October 2003 Diabetic ketoacidosis ketones fell faster on an extended insulin regimen. Level of evidence 1b Expiry Date October 2003 Diabetic ketoacidosis no clear difference between route of insulin administration. Level of evidence 1b- Expiry Date October 2003 Diabetic ketoacidosis no clear difference between intramuscular and intravenous insulin. Level of evidence 1b- Expiry Date October 2003 Diabetic ketoacidosis increased infection rates with phosphate infusions. Level of evidence 1b Expiry Date October 2003 Diabetic ketoacidosis no clear benefit from high-dose insulin infusions. Level of evidence 2b- Expiry Date October 2003 Diabetic ketoacidosis no clear role for bicarbonate. Level of evidence 1b- Expiry Date October 2003 Diabetic ketoacidosis no clear role for bicarbonate. Level of evidence 1b- Expiry Date October 2003